Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (129K) Freely available
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Nawrot, B.
Right arrow Articles by Stec, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nawrot, B.
Right arrow Articles by Stec, W. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research Pages 2650-2658  


Novel internucleotide 3[prime]-NH-P(CH3)(O)-O-5[prime] linkage. Oligo(deoxyribonucleoside methanephosphonamidates); synthesis, structure and hybridization properties
Introduction
Materials And Methods
   N-[5[prime]-O-(4,4[prime]-Dimethoxytrityl)-3[prime]-amino-3[prime]-deoxythymidin-3[prime]-yl]-O-(3[prime]-O-acetylthymidin-5[prime]-yl)-methanephospho-namidates (4a and 4b) and bis-O,O-(3[prime]-O-acetylthymidin-5[prime]-yl)-methanephosphonate (4c)
   Removal of acetyl protecting group from 4a and 4b
   Removal of the DMT protecting group from 5a and 5b
   Phosphitylation of 5a and 5b
   Oligonucleotide synthesis
   Oligonucleotide labeling
   Assay for enzymatic digestion of diastereomers 6a and 6b
   Assay for stability of diastereomers 6a and 6b at pH 3 and pH 11
   Assay for enzymatic digestion of dodecathymidylates F1-F4 and S1-S4
   Assay for digestion of oligonucleotides with 3[prime]-exonuclease from human plasma
   Melting experiments
Results
   Synthesis of dithymidine methanephosphonamidates
   Structure of dinucleoside methanephosphonamidates
   Conformation of sugar rings in dinucleotides 6a and 6b
   Absolute configuration of dithymidine methanephosphonamidates
   Stability of dimers 6a and 6b
   Oligodeoxyribonucleotides: synthesis, deprotection and purification
   Structures of oligodeoxyribonucleotides
   Enzymatic degradation of oligo(thymidine methanephosphonamidates)
   Human plasma 3[prime]-exonuclease digestion
   Hybridization properties
   Triplex formation
   CONCLUSIONS
Acknowledgements
References


Novel internucleotide 3[prime]-NH-P(CH<sub>3</sub>)(O)-O-5[prime] linkage. Oligo(deoxyribonucleoside methanephosphonamidates); synthesis, structure and hybridization properties

Novel internucleotide 3[prime]-NH-P(CH3)(O)-O-5[prime] linkage. Oligo(deoxyribonucleoside methanephosphonamidates); synthesis, structure and hybridization properties

Barbara Nawrot*, Malgorzata Boczkowska, Marzena Wójcik, Marek Sochacki, Slawomir Kazmierski, Wojciech J. Stec

Department of Bioorganic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lódz, Poland

Received February 13, 1998; Revised and Accepted April 17, 1998

ABSTRACT

Diastereomeric dithymidine methanephosphonamidates (TnpmT) were synthesized by reaction of 3[prime]-amino-3[prime]-deoxythymidine with 3[prime]-O-acetylthymidin-5-yl-methanephosphonochloridate. Separated dinucleotide TnpmT(fast) and TnpmT(slow) diastereomers were used as building blocks to prepare chimeric dodecathy-midylates, possessing one to four modified linkages, by means of phosphoramidite automated solid phase synthesis. As expected, the methanephosphonamidate internucleotide linkage is resistant to nuclease P1, snake venom PDE and 3[prime]-exonuclease from human plasma. Degradation of dodecathymidylates possessing modified internucleotide linkages in alternate positions proved the `hopping' properties of 3[prime]-exonuclease. Oligo(deoxyribonucleotide methanephosphonamidates) were tested for their binding affinity to complementary oligomers in thermal denaturation experiments. All the oligomers showed lower binding affinity to DNA and RNA targets, however, oligomers originating from the TnpmT(fast) dimeric unit exhibited better hybridization properties than their diastereomeric TnpmT(slow) counterparts. A lowering of Tm of ~2.4°C (1.0-1.8°C) was observed for each introduced TnpmT(fast) modification and 6.0°C (4.2-5.0°C) for each TnpmT(slow) modification in duplexes of modified dodecathymidylates with dA12 (A12) oligomers. The oligo(deoxyribonucleoside methanephosphonamidate) designated F4, possessing four modified methanephosphonate linkages originating from the TnpmT(fast) diastereomeric unit, exhibits a tendency for triplex formation, as was demonstrated in thermal denaturation experiments with the d(A21C4T21) hairpin oligomer.

INTRODUCTION

It is generally accepted that the high avidity of oligonucleotide analogs for complementary DNA or RNA strands promotes them as good candidates for the antisense strategy (1). Other required properties of potential antisense therapeutics include a requirement for stability against endo- and exonucleases, enhanced cellular uptake and low affinity for proteins (2). With respect to the first generation of antisense constructs such expectations were met by oligo(nucleoside methanephosphonates) of the [RP] configuration (3,4), albeit that their limited solubility in physiological media and pharmacokinetics (fast influx and fast efflux; 5) limited their practical application. However, mixed backbone oligonucleotides possessing phosphorothioate core oligonucleotides flanked by short fragments of [RP] methanephosphonates have recently been presented as promising second generation antisense constructs (6,7). In parallel, Gryaznov et al. (8-12) introduced another second generation antisense construct possessing an internucleotide phosphoramidate 3[prime]-HN-P(O)O--O5[prime] backbone. N3[prime]-P5[prime] phosphoramidate oligonucleotides, besides stability to phosphodiesterases, possess excellent hybridization properties towards RNA and single- or double-stranded DNA (9). The mostly appreciated property of N3[prime]-P5[prime] oligonucleotides is their low affinity for proteins, in contrast to oligo(nucleoside phosphorothioates) (12). Taking into account the advantageous properties of [Rp] methanephosphonates and N3[prime]-P5[prime] phosphoramidates it was tempting to prepare new oligonucleotides with incorporated structural motifs related to both aforementioned classes of oligomers, namely methanephosphonamidates.

Here we describe synthesis of nucleotide dimers linked by a new class of internucleotide linkage, 3[prime]-NH-P(CH3)(O)-O-5[prime]. Analogous to methanephosphonates, non-stereospecific synthesis of dinucleoside methanephosphonamidates leads to a mixture of two, [Sp] and [Rp], diastereomers. Dinucleoside methanephosphonamidates are nuclease P1- and svPDE-resistant and relatively stable in basic and acidic media. Therefore, dinucleoside methanephosphonamidates are attractive building blocks for the synthesis of chimeric oligodeoxyribonucleotides designed as potential antisense agents. Several thymidine dodecamers with one to four modified internucleotide bonds, originating from particular diastereomeric dithymidine methanephosphonamidates, have been prepared. Their stability to nuclease P1 and 3[prime]-exonuclease from human plasma as well hybridization properties are discussed.

MATERIALS AND METHODS

The nuclear magnetic resonance spectra were recorded using a Bruker AC-200 instrument at 200.13 MHz for 1H and 81.33 MHz for 31P. Chemical shifts ([delta]) are given in p.p.m. If not indicated samples were dissolved in CDCl3. The solvent signal was used as internal standard for 1H ([delta] CDCl3 = 7.26 p.p.m., [delta] CD3OD = 3.31 p.p.m.) and 85% H3PO4 as the external standard for 31P. ROESY spectra were recorded using a Bruker DRX 500 at 500.13 MHz for 1H in a 2 × 0.5k (F2 × F1) data point matrix. Total deviation of the spin lock was set to 350 ms. Data were processed with the SINE function in both dimensions. Zero filling up to 1k data points was applied in F1. No zero filling was applied in F2. Spectra were collected for samples dissolved in CDCl3 (5 mM). The LSIMS spectra (Cs+, 13 keV) were recorded on a Finnigan MAT 95 spectrometer and MALDI-TOF MS spectra were done on a Voyager-Elite instrument (PerSeptive Biosystems, CT) in reflector mode, at a resolution of 2000. Ultraviolet (UV) spectra were recorded on a Kontron Uvikon 860 spectrophotometer. Circular dichroism (CD) spectra were recorded on a Jobin Yvon CD 6 Dichrograph in 10 mM Tris, pH 7.5, 100 mM NaCl, 10 mM MgCl2. HPLC analyses were performed on an LDC Analytical System (pumps CM 3500 and CM 3200) SpectroMonitor SM4100 equipped with an Econosphere C18 column (4.6 × 25 mm; Alltech). The following solvent systems were used: method A, an acetonitrile gradient in 0.1 M NH4OAc (0-40% acetonitrile) over 20 min; method B, 0.1 M triethylammonium bicarbonate/acetonitrile 0-40% gradient over 30 min, flow rate, 1 ml/min. Preparative purifications were performed on an LDC Milton Roy instrument equipped with a PRP-1 column (305 × 7.0 mm; Hamilton) eluted with a 0.1 M triethylammonium bicarbonate/acetonitrile 0-50% gradient, flow rate 3 ml/min. Evaporations were carried out at 40°C using a water or oil pump vacuum. Freeze drying was done in a Lyovac instrument. TLC was carried out on silica gel 60 F254 plates (Merck, Germany) in chloroform/methanol; (A) 9/1 v/v, (B) 8/2 v/v. Thymidine was purchased from Pharma Waldhof (Germany). Melting curves were recorded with a GBC 916 UV/VIS spectrophotometer in 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl2.

Snake venom phosphodiesterase (svPDE, EC 3.1.15.1) and alkaline phosphatase (EC 3.1.3.1) were from Boehringer Mannheim (Mannheim, Germany). Nuclease P1 (EC 3.1.30.1) was from Sigma. T4 polynucleotide kinase (EC 2.7.1.78) was from Amersham USA. Human plasma was isolated from human blood as described (13).

N-[5[prime]-O-(4,4[prime]-Dimethoxytrityl)-3[prime]-amino-3[prime]-deoxythymidin-3[prime]-yl]-O-(3[prime]-O-acetylthymidin-5[prime]-yl)-methanephospho-namidates (4a and 4b) and bis-O,O-(3[prime]-O-acetylthymidin-5[prime]-yl)-methanephosphonate (4c)

3[prime]-O-Acetylthymidine (1, 1.7 mmol, 483 mg) was dissolved in anhydrous pyridine (5 ml) and added at 0°C to the stirred solution of dichloromethanephosphonate (2.5 mmol, 340 mg) (14) in anhydrous pyridine (5 ml). After 15 min 5[prime]-O-DMT-3[prime]-amino-3[prime]-deoxythymidine (3, 1.7 mmol, 937 mg) (10) in anhydrous pyridine (5 ml) was added dropwise to the reaction mixture and stirred for 2 h at room temperature. Addition of chloroform (300 ml) followed by subsequent washings with saturated sodium bicarbonate (2 × 100 ml) and water (100 ml) and concentration in vacuo afforded a mixture of products which were separated on silica gel by flash column chromatography with a gradient (0-5%) of methanol in chloroform. 4a (110 mg, 7.3%), 4b (138 mg, 9.1%) and 4c (131 mg, 10.5%) were obtained. Rf, 31P NMR and MS data for dinucleotides 4a, 4b and 4c are given in Table 1. 1H NMR data are available in Supplementary Material (PDF 86 KB).

Removal of acetyl protecting group from 4a and 4b

Protected dimer 4a (120 mg) was treated with concentrated ammonium hydroxide (7 ml)/ethanol (7 ml) mixture and kept for 17 h at 4°C. Removal of solvents in vacuo and subsequent co-evaporation with anhydrous toluene (3 × 5 ml) followed by flash column chromatography purification on silica gel in a methanol/chloroform gradient (0-7 %) afforded 5a (103 mg, 90%). Analogous deprotection of the acetyl group of 4b gave 5b with a yield of ~90%. Selected spectral and chromatographic data for 5a and 5b are given in Table 1.

1H NMR data are available in Supplementary Material (PDF 86 KB).

Removal of the DMT protecting group from 5a and 5b

Deprotection was performed with 80% acetic acid at 50°C for 20 min. After freeze drying the products were purified by flash column chromatography on silica gel in a methanol/chloroform (0-10%) gradient. Deprotected dimers 6a and 6b were obtained with yields >90%. Selected spectral and chromatographic data for 6a and 6b are given in Table 1. 1H NMR data are available in Supplementary Material (PDF 86 KB).

Table 1. Spectral and chromatographic characteristics of dithymidine methanephosphonamidates 4-7
Dimer TLC 31P-NMRc FAB MS
TnpmT mobilitya [delta] (p.p.m.) JP-Me (Hz) Calculated Found
4a 0.60 34.19 16.57 886.3064 886.3063
4b 0.51 34.78 16.48 886.3064 886.3068
4c 0.63 33.03 17.50 628.1782 628.1729
5a 0.29 35.13 16.70 844.2959 844.2935
5b 0.29 36.15 16.55 844.2959 844.2927
6a 0.11b 36.96d 16.68 542.1641 542.1652
6b 0.12b 37.30d 16.67 542.1641 542.1652
7a 0.57 34.53   1044 1043.5
    34.23     [M-H]+
    149.44      
    149.22e      
7b 0.54 34.55   1044 1045.2
    34.44     [M+H]+
    149.64     1043.0
    149.06e     [M-H]+
aIf not indicated otherwise, TLC was determined in solvent system (A).
bSolvent system (B), as described in Materials and Methods.
cIf not indicated otherwise, NMR spectra were recorded in CDCl3.
dIn CD3OD.
eIn methylene chloride.

Table 2. Sequences and HPLC and MS data for oligo(deoxyribonucleoside methanephosphonamidates) F1-F4 and S1-S4
ODN Parent dimer TnpmT Oligonucleotide sequence HPLCa (Rt/purity) HMALDI-TOF MS
      Min % Calculated Found
T12   TpTpTpTpTpTpTpTpTpTpTpT     3587.6 3587.6
F1 4a, fast TpTpTpTpTpTnpmTpTpTpTpTpT 16.55 98.0 3584.6 3583.8
F2 4a, fast TpTpTpTpTnpmTpTnpmTpTpTpTpT 17.05 >99.0 3581.6 3581.3
F3 4a, fast TpTpTpTnpmTpTnpmTpTnpmTpTpTpT 17.25 >99.0 3578.6 3578.7
F4 4a, fast TpTpTnpmTpTnpmTpTnpmTpTnpmTpTpT 17.20 >99.0 3575.6 3575.7
S1 4b, slow TpTpTpTpTpTnpmTpTpTpTpTpT 16.80 99.0 3584.6 3584.6
S2 4b, slow TpTpTpTpTnpmTpTnpmTpTpTpTpT 17.08 >99.0 3581.6 3581.1
S3 4b, slow TpTpTpTnpmTpTnpmTpTnpmTpTpTpT 17.02 >99.0 3578.6 3578.7
S4 4b, slow TpTpTnpmTpTnpmTpTnpmTpTnpmTpTpT 17.30 >99.0 3575.6 3575.9
aAnalytical purity determination was performed chromatographically on a C18 column according to the conditions described in Materials and Methods.

Phosphitylation of 5a and 5b

2-Cyanoethyl tetraisopropylphosphorodiamidite (75 mg, 0.21 mmol) was added under argon to a solution of dimer 5a (175 mg, 0.2 mmol) and IH-tetrazole (84 mg, 0.2 mmol) in anhydrous methylene chloride (2 ml). The reaction mixture was stirred for 3 h at room temperature and then loaded under argon onto a silica gel column. The product was eluted with a gradient (0-5%) of methanol in methylene chloride, concentrated in vacuo and stored under argon at -20°C. Yield of 7a 193 mg (92%). Phosphitylation of 5b was done analogously to afford 7b (160 mg, 71%). Selected spectral and chromatographic data for 7a and 7b are given in Table 1.

Oligonucleotide synthesis

Modified dodecathymidylates, F1-F4 and S1-S4, were prepared by the phosphoramidite method on an ABI 391 synthesizer at the 0.5-1.0 µmol scale. Dinucleotide phosphoramidities 7a and 7b were used as solutions in acetonitrile at concentrations of 0.08-0.12 M. Purification of all oligonucleotides was carried out by two-step RP-HPLC (DMT-on and DMT-off) (15).

Oligonucleotide labeling

Oligonucleotides listed in Table 2 were 5[prime]-end-labeled with [[gamma]-32P]ATP and T4 polynucleotide kinase according toKoziolkiewicz et al. (13).

Assay for enzymatic digestion of diastereomers 6a and 6b

Diastereomers 6a or 6b (0.57 mM) was dissolved in 100 mM Tris-HCl, pH 7.2, and 1 mM Zn2+ buffer (100 µl) or in 100 mM Tris-HCl, pH 8.0, and 20 mM MgCl2 (100 µl) and incubated with nuclease P1 (2 µg) or with svPDE (2 µg) respectively at 37°C for 15 h. The enzyme was denaturated by heating at 95°C for 10 min and the reaction mixture was centrifuged for 10 min at 10 000 r.p.m. (Biofuge 13; Heraeus). The reaction products were analyzed by means of HPLC according to method A.

Assay for stability of diastereomers 6a and 6b at pH 3 and pH 11

Diastereomers 6a or 6b (0.57 mM) were dissolved in 100 mM ammonium hydroxide/acetic acid pH 3 or pH 11 buffer and incubated for 15 h at 37°C. The products were analyzed by means of HPLC according to method A.

Assay for enzymatic digestion of dodecathymidylates F1-F4 and S1-S4

Dodecathymidylates F1-F4 and S1-S4 (0.1 mM) were dissolved in 100 mM Tris-HCl, pH 7.2, and 1 mM Zn2+ buffer (20 µl) and incubated with nuclease P1 (2 µg) at 37°C for 18 h. Then the reaction mixture was incubated with alkaline phosphatase (2 µg) at 37°C for 3 h. The enzymes were denaturated by heating at 95°C for 10 min and the reaction mixture was centrifuged for 10 min at 10 000 r.p.m. The reaction products were analyzed by means of HPLC according to method A.

Assay for digestion of oligonucleotides with 3[prime]-exonuclease from human plasma

The samples of oligonucleotides (10 µM) in phosphate-buffered saline, pH 7.5, were mixed with an equal volume of human plasma and incubated at 37°C. At various times (0, 20, 60, 120 and 240 min) 10 µl aliquots were withdrawn and the enzymatic reaction was quenched by heating for 2 min at 95°C. Then, 100 µl water were added to each denatured sample. After vigorous shaking, the protein precipitates were spun down and the aqueous solutions were dissolved in formamide containing 0.03% bromophenol blue and 0.03% xylene cyanol (5-8 µl) and analyzed by 20% polyacrylamide/7 M urea gel electrophoresis.

Melting experiments

Melting temperature measurements of duplexes obtained by hybridization of modified oligomers F1-F4 and S1-S4 with the dA12 target were performed in 10 mM Tris-HCl, pH 7.5, 100 mM NaCl and 10 mM MgCl2 with various oligonucleotide concentrations (1 × 10-6-6 × 10-6 M). Measurements of melting temperatures of oligomers F2-F4 and S2-S3 with A12 were done at a concentration of 3 × 10-6 M duplex. Triplex melting experiments for oligonucleotides T12, F4 or S4 with the d(A21C4T21) hairpin oligonucleotide were carried out in 10 mM Tris-HCl, pH 7.5, 0.5 M NaCl and 10 mM MgCl2 at a concentration of 2 × 10-6 M each oligomer. Oligonucleotides at the appropriate concentrations based on UV 260 nm absorbance were mixed and heated at 60°C for 5 min, allowed to cool to room temperature and kept overnight at 4°C. Melting profiles were recorded from 3 to 80°C with a temperature gradient of 0.2°C/min. All measurements were carried out in a 1 cm path length cell with a GBC UV/VIS 916 spectrophotometer equipped with a Peltier Thermocell.


Scheme 1.

RESULTS

Synthesis of dithymidine methanephosphonamidates

A one-pot strategy has been chosen for the synthesis of dimeric nucleotides with a modified internucleotide bond. As monomeric units we used 5[prime]-O-DMT-protected 3[prime]-amino-3[prime]-deoxythymidine 3 (10) and 3[prime]-O-acetyl-protected thymidine 1 (Scheme 1). The applied standard protecting groups allowed the use of basic deprotection for the removal of acetyl groups and further functionalization of the 3[prime]-end of the dimer, while the acid-labile dimethoxytrityl group at the 5[prime]-end was suitable for solid phase synthesis of oligomers. Reaction of 3[prime]-O-acetylthymidin-5[prime]-yl-methanephosphonochloridate 2 with 3[prime]-amino-3[prime]-deoxythymidine 3 resulted in a mixture of two diastereomeric dimers, 4a [TnpmT(fast), TLC-fast migrating diastereomer] and 4b [TnpmT(slow), TLC-slow migrating diastereomer] as well as symmetrical bis-(3[prime]-O-acetylthymidyn-5[prime]-yl)-methanephosphonate 4c in the ratio 1:1:2. Diastereomers 4a and 4b and by-product 4c were separated by column chromatography on silica gel in a methanol/chloroform gradient. The total yield of isolated products was <30% and was not optimized. Dinucleotide units for solid phase synthesis were prepared by routine 3[prime]-end deprotection of 4a and 4b under basic conditions (ethanolic ammonium hydroxide), to give 5a and 5b respectively. Subsequent phosphitylation with 2-cyanoethyl tetraisopropylaminephosphorodiamidite afforded phosphoramidities 7a and 7b in 92 and 71% yield respectively (Scheme 1).

Structure of dinucleoside methanephosphonamidates

The structures of dinucleoside methanephosphonamidates 4, 5 and 6 were determined by NMR, MS and CD analysis. Spectral data (31P and MS) are given in Table 1. The 31P NMR chemical shifts of phosphorus in dinucleoside methanephosphonamidates fall in the range 34-37 p.p.m. and differ slightly for the two diastereomers of each pair of dimers (Table 1), exhibiting an upfield shift for diastereomers 4a and 6a. The same upfield chemical shifts for P-Me protons within each pair of dimers were observed in 1H NMR spectra of diastereomers originating from 4a (data available in Supplementary Material (PDF 86 KB)).

The structural differences between dithymidine phosphate and both diastereomeric dithymidine methanephosphonamidates are reflected in the CD spectra. Those of 6a and 6b (available in Supplementary Material (PDF 86 KB)) are almost identical in the region between 245 and 300 nm. However, they differ in shape and intensity in the range 210-245 nm. Further studies on the properties of diastereomeric dithymidine methanephosphonamidates are in progress.

Conformation of sugar rings in dinucleotides 6a and 6b

Deoxyribonucleosides adopt predominantly the 2[prime]-endo sugar ring conformation in solution and in the solid state (16). A typical B-DNA helix also exhibits 2[prime]-endo sugar ring puckering (17). The conformational preferences observed for the sugar ring in various 3[prime]-substituted 3[prime]-deoxythymidine derivatives strongly depend on the electronegativity of the 3[prime]-substituent (18). Modification of 2[prime]-deoxyribonucleosides to 3[prime]-amino-2[prime],3[prime]-dideoxyribonucleosides increases the population of the 3[prime]-endo conformer, both in nucleosides (18) and in oligonucleotides originating from these modified units (19). The conformation of the sugar rings of dithymidine methanephosphonamidates 6a and 6b was elucidated routinely using an empirical method of analysis of the vicinal coupling constants 3J1[prime]2[prime] and 3J1[prime]2[prime][prime] (Table 3; 20). The population of the 2[prime]-endo sugar ring conformer (% S) was calculated from the equation % S = (3J1[prime]2[prime] + 3J1[prime]2[prime][prime] - 9.8)/5.9 (20). As shown in Table 3, both diastereomers prefer the same mode of ring pucker. The 5[prime]-terminal nucleoside (Tn) riboses take predominantly the 3[prime]-endo conformation, whereas unmodified sugars at the 3[prime]-terminus (pT) exhibit predominantly the 2[prime]-endo ring pucker. Comparison of these datawith conformational data for the parent dimers: dithymidine phosphate (TpT), dithymidine phosphoramidate (TnpT) (19) and dithymidine methanephosphonate (TpmT) (21) indicates a preference for the 2[prime]-endo sugar ring conformation for dinucleotide TpT and for 3[prime]-terminal nucleosides in TnpT and in TnpmT dimers. Dithymidine methanephosphonates exist in an equimolar equilibrium of both conformational isomers. However, distinct conformational changes are observed for5[prime]-terminal sugar of TnpT and both TnpmT dimers. In these cases the 2[prime]-endo conformer is a minor one. The presence of a less electronegative 3[prime]-amino group in 3[prime]-amino-3[prime]-deoxy modified dinucleotides induces their A-type structure. Most probably, this property promotes oligo(deoxyribonucleoside phosphoramidates) as high affinity complements for hybridization with target RNAs (9,19). In this respect novel oligo(deoxyribonucleoside methanephosphonamidates) are promising compounds for further investigations.

Table 3. Conformational analysis of sugar residues in dithymidylates TxT, where bond x means: p, phosphate; np, 3[prime]N-P5[prime] phosphoramidate; pm, methanephosphonate; npm, 3[prime]N-P5[prime] methanephosphonamidate bond. The 2[prime]-endo conformer population (% S) is determined from the sum of coupling constants of H-1[prime] and H-2[prime] and H-2[prime][prime] (3J1[prime]-2[prime] and 3J1[prime]-2[prime][prime]), according to Rinkel and Altona (20)
Dinucleotide TxT   [Sigma]3J1[prime]2[prime] (Hz) % S Predominant sugar
ring pucker
TpT (19) Tp 13.8 68 2[prime]-endo
  pT 13.4 61 2[prime]-endo
TnpT (19) Tn 9.4 0 3[prime]-endo
  pT 13.8 68 2[prime]-endo
TpmT(fast)a (21) Rp Tpm 13.0 54 2[prime]-endo/3[prime]-endo
  pT 13.1 56 2[prime]-endo/3[prime]-endo
TpmT(slow)a (21) Sp Tpm 13.0 54 2[prime]-endo/3[prime]-endo
  pT 12.8 51 2[prime]-endo/3[prime]-endo
TnpmT(fast) 6a Tn 11.7 32 3[prime]-endo
  pT 13.4 61 2[prime]-endo
TnpmT(slow) 6b Tn 11.0 20 3[prime]-endo
  pT 13.4 61 2[prime]-endo
aAs 5[prime]-DMT derivatives.

Absolute configuration of dithymidine methanephosphonamidates

Dinucleoside (3[prime]N->P5[prime]) methanephosphonamidates constitute a new class of derivatives for which neither spectral nor crystallographic data are available. Therefore, our assignment of absolute configuration at the phosphorus is based on data reported for the structurally related methanephosphonates (22-25). In only a very few cases was the absolute configuration of the dinucleoside methanephosphonates determined by X-ray analysis (26,27). However, there are some spectral features, common within particular diastereomeric series, which can be used to predict the stereochemistry of chiral phosphorus centers by means of UV, CD and NMR spectroscopy (24). Fast migrating dinucleoside methanephosphonates were always identified as [Rp] diastereomers by means of TLC (protected TpmT) and HPLC (deprotected TpmT). [Rp] diastereomers exhibit an upfield chemical shift of the phosphorus atom in 31P NMR (22). The same upfield chemical shift is observed for P-Me group protons in 1H NMR (22). The profiles of CD spectra for pairs of dimers are similar, but differ in magnitude of molecular ellipticity, with higher values for the fast migrating isomer [Rp] due to the different mode of base stacking and different overall structure (24). Taking into account the above arguments, tentative assignment of the absolute configuration of the phosphorus atom in dinucleoside methanephosphonamidates 4a-7a [TnpmT(fast)] as [Rp] is proposed. This assignment was made on the basis of the following data: (i) the fast migrating protected dimer is the 4a dimer (Table 1); (ii) upfield shifted signals of the phosphorus in 31P NMR spectra are obtained for the 4a, 5a, 6a and 7a derivatives (Table 1); (iii) upfield shifted signals of P-Me group protons in 1H NMR spectra are obtained for the 4a and 6a derivatives (data available in Supplementary Material (PDF 86 KB)); (iv) the CD spectrum of 6a exhibits a slightly higher magnitude of the peaks at 215 and 245 nm.

The stereochemistry of the chiral phosphorus center in dinucleoside methanephosphonates was also investigated and predicted on the basis of NMR data with application of a ROESY technique (22,23,25). As was shown for dinucleoside methanephosphonates, nuclear Overhauser effects (NOEs) between H-3[prime], H-4[prime] and H-5[prime] ribose protons and protons of the phosphorus methyl group strongly depend on the absolute configuration of the phosphorus and were used as a criterion to distinguish between [Sp] and [Rp] diastereomers. The absolute phosphorus configuration the NOE of P-Me to H-4[prime] of the 5[prime]-terminal nucleoside was used as diagnostic for [Rp] (22). The presence of a distinct cross-peak between P-Me and H-3[prime] of the 5[prime]-terminal nucleoside was reported to be a criterion for assignment of the [Sp] phosphorus configuration (23), however further investigations of a variety of dimeric methanephosphonates only partially support this assumption (24). In some cases both diastereomers exhibit NOE cross-peaks of P-Me to H-3[prime] of the 5[prime]-terminal nucleoside (22). NOE cross-peaks of P-Me to H-5[prime] and H-5[prime][prime] of the 3[prime]-terminal nucleoside were also detected for the [Rp] dimer (22). Thus, further assignment of absolute configuration of the phosphorus center in dithymidine methanephosphonamidates is based on NOEs between P-Me group protons and protons of the ribose moieties of the fully protected dimers 4a and 4b (Fig. 1a and b respectively). In the extended part of the ROESY spectrum of fast migrating diastereomer 4a (Fig. 1a) the strongest cross-peak originates from interaction of P-Me protons with H-3[prime] of Tn or H-5[prime] of pT sugars protons. Analysis of the overlapping signals shows that the upfield part of the broad signal represents the H-5[prime] proton of pT. Thus, the strongest cross-peak which is present in the spectrum of fast migrating diastereomer 4a originates from the interaction between P-CH3 and H-5[prime] of pT protons. Also, cross-peaks from P-Me to H-4[prime] of Tn and H-4[prime] of pT are present. A ROESY spectrum of slow migrating diastereomer 4b (Fig. 1b) shows one distinct cross-peak from the P-Me protons to the H-3[prime] and H-4[prime] protons of the Tn ribose moiety. Unfortunately, an overlap of these H-3[prime] and H-4[prime] proton resonances does not allow us to assign NOE interactions for particular nuclei. However, in the ROESY spectrum of fully deprotected dimer 6b (data not shown) two cross-peaks of similar intensity from P-Me to the H-3[prime] and H-4[prime] protons of Tn are present, thus indicating both P-Me-H3[prime] and P-Me-H4[prime] interactions. Although the diagnostic NOEs of dinucleoside methanephosphonamidates are similar to those of dinucleoside methanephosphonates, in the spectra of both diastereomers 4a and 4b strong interactions between P-Me and H-4[prime] of Tn are present. This could be due to the shorter P-N bond (1.73 Å) in methanephosphonamidates than the P-O bond (1.79 Å) in the parent methanephosphonates, causing a decrease in the P-Me-H-4[prime] interatomic distance and, thus, enhancing the NOE interaction. Molecular modeling of dithymidine methanephosphonamidates 6a and 6b with the help of the HyperChem program (MM+ method) results in a structure of the [Rp] diastereomer with the closest P-CH3-H-5[prime] of pT contact (2.37 Å). In contrast, the model structure of the [Sp] diastereomer has the P-CH3-H-3[prime] of Tn distance as the closest contact. Thus, assignment of the absolute configuration at the phosphorus atom as [Rp] for fast migrating dimer 4a and [Sp] for slow migrating dimer 4b is proposed.

Figure 1. Extended plot of ROESY spectra of 5[prime]-DMT, 3[prime]-Ac-protected dithymidine methanephosphonamidates 4a [TnpmT(fast), (a)] and 4b [TnpmT(slow), (b)]. Cross-peaks of P-Me and ribose protons are shown. Tn and pT correspond to ribose protons of the 5[prime]-terminal and 3[prime]-terminal nucleoside respectively.


Figure 2. Gel electrophoresis of 5[prime]-32P-labeled oligo(deoxyribonucleoside methanephosphonamidates) F1-F4 (lanes 2, 4, 6 and 8) and S1-S4 (lanes 3, 5, 7 and 9) (20% polyacrylamide, 7 M urea). A mobility retardation effect is observed due to introduction of a non-ionic modified internucleotide linkage. For comparison dodecathymidylate (lanes 1 and 10) is shown.


Stability of dimers 6a and 6b

Fully deprotected dimers 6a and 6b were tested for their stability at pH 3 and pH 11 at 37°C for 15 h. Stability of dimers 6a and 6b to Penicillum citrinum nuclease P1 and svPDE at 37°C for 15 h was also checked. HPLC profiles of the mixtures before [peak of TnpmT(fast) at Rt = 12.82 min, peak of TnpmT(slow) at Rt = 13.30 min] and after incubation (peaks exclusively at 12.80 or 13.23 min) (according to method A, Materials and Methods) are identical (data not shown). Thus, dithymidine methanephosphonamidates are stable under a broad range of pH conditions and are resistant to enzymatic cleavage.

Oligodeoxyribonucleotides: synthesis, deprotection and purification

Two series of chimeric thymidine dodecamers, containing one to four dithymidine methanephosphonamidate (TnpmT) blocks incorporated into the oligodeoxyribonucleotide chain, were obtained by the phosphoramidite approach (Table 2; 28). Oligomers originating from dimer 4a [TnpmT(fast)] are designated F and those originating from dimer 4b [TnpmT(slow)] are designated S. Average coupling yields of dimeric units were 86-96% per step, as judged by DMT cation assay. Oligomers were purified before and after DMT removal by means of reverse phase HPLC with a triethylammonium bicarbonate (pH 7.0)/acetonitrile gradient. The purity of the oligomers was checked by HPLC analysis on a C18 column according to method B (Materials and Methods) (Table 2) and by 20% polyacrylamide/7 M urea gel electrophoresis of 5[prime]-32P-labeled samples (Fig. 2). The mobilities of oligomers with modified internucleotide bonds were compared with the mobility of non-modified homopolymer T12. Subsequent mobility retardation of oligomers F1-F4 (lanes 2, 4, 6 and 8) and S1-S4 (lanes 3, 5, 7 and 9) in comparison with the mobility of T12 (lanes 1 and 10) occurs due to increasing participation of hydrophobic, non-ionic methanephosphonamidate internucleotide linkages in the overall structure of oligomers within a particular series. The determined purity of all oligomers was [ge]98%. Oligomers of both series show the correct molecular mass values as determined by MALDI-TOF mass spectrometry (Table 2).

Structures of oligodeoxyribonucleotides

The structures of oligodeoxyribonucleotides F1-F4, S1-S4, the reference T12 and their heteroduplexes with dA12 or A12 were investigated by CD measurements. The respective CD spectra are available in Supplementary Material (PDF 86 KB). The spectra of single-stranded oligomers are almost identical. The CD profiles for DNA/DNA duplexes also do not differ for the particular modifications. They show positive peaks at 280 nm and intense negative ones at 250 nm and belong to the B-DNA family. Modified oligomers as well as the T12 oligomer hybridized with RNA exhibit positive bands around 265 nm and negative ones at 250 nm. Their structure can be assigned to the A-DNA family of duplexes from the shape of the spectra (17). Unlike double-stranded DNA/DNA, in this case the presence of four modified linkages (as in the F4 and S4 oligomers) causes a significant increase in the intensity of the 265 nm bands. This difference probably reflects the more A-type character of F4/RNA and S4/RNA duplexes in comparison with the duplex T12/RNA.

Enzymatic degradation of oligo(thymidine methanephosphonamidates)

As indicated above, the methanephosphonamidate internucleotide bond in dinucleotides 6a and 6b is stable against nucleases P1 and svPDE. Exhaustive enzymatic digestion of oligomers F1-F4 and S1-S4 with Penicillum citrinum nuclease P1 (18 h, 37°C) and calf intestine alkaline phosphatase (3 h, 37°C) in 100 mM Tris-HCl, pH 7.2, and 1 mM Zn2+ buffer resulted in thymidine and dimer 6a [TnpmT(fast)] or 6b [TnpmT(slow)] respectively. The digests were analyzed by HPLC on a C18 column with an acetonitrile/0.1 M ammonium acetate (pH 7.0) gradient. Two main peaks detected at 10.05 and 12.87 min or alternatively 13.53 min were assigned as the peaks of thymidine and dimer 6a or dimer 6b respectively, by means of co-injection with genuine samples (data not shown). Numeric peak integration was in accordance with the calculated values. Shorter incubation times caused only partial digestion of the oligomers, resulting in HPLC profiles showing several peaks with Rt longer than that of thymidine. The ratio of the peaks of thymidine to the sum of the peaks with longer retention times (assigned as TnpmT, pTnpmT, TnpmTpTnpmT, pTnpmTpTnpmT etc.) was in agreement with the expected values for particular oligomers. Relatively slow degradation of modified oligomers is a consequence of the presence of alternative phospodiester and methanephosphonamidate bonds, thus making phosphodiester bonds less accessible to the endonuclease.


Figure 3. Gel electrophoresis of products of 3[prime]-exonuclease degradation of oligo(deoxyribonucleoside methanephosphonamidates) F1-F4 (lanes 2-5) and S1-S4 (lanes 6-9) (20% polyacrylamide, 7 M urea). Incubation with 3[prime]-exonuclease of a 50% saline solution of human plasma was for 4 h at 37°C. Resistance of the methanephosphonamidate linkage toward 3[prime]-exonuclease degradation results in shorter oligonucleotides possessing TnpmT dimers at their 3[prime]-ends (lanes 2-5 and 6-9). For comparison, degradation of dodecathymidylate T12 is shown (lane 1). Bands of lower intensity in lanes 2-9 correspond to the products of degradation due to the `hopping' properties of 3[prime]-exonuclease.


Human plasma 3[prime]-exonuclease digestion

Dodecathymidylates F1-F4 and S1-S4 and the reference T12 were used to study their stability to 3[prime]-exonuclease from human plasma (13). Substrates labeled at the 5[prime]-end with [32P]phosphate were incubated in 50% saline solution of human plasma for 4 h and then analyzed on a 20% polyacrylamide gel containing 7 M urea (Fig. 3). Non-modified oligomer T12 is digested to a ladder of products from T11 to T2 (lane 1). The oligomers F1-F4 (lanes 2-5) and S1-S4 (lanes 6-9) containing modified internucleotide bonds are degraded only partially. Degradation proceeds from the 3[prime]-terminus of the oligomers and is stopped by the presence of a modified internucleotide linkage. Thus, the remaining non-degraded oligomers contain the modified unit TnpmT at their 3[prime]-ends. For example, both the F1 and S1 oligomers (lanes 2 and 6 respectively) are digested to oligomers containing from n - 1 to n - 5 nucleotides. It is noteworthy that in the course of digestion, which starts from the 3[prime]-end of the oligomers, the ratio of charged internucleotide linkages to methanephosphonamidate linkages drops. Therefore, the products originating from modified oligomers F1-F4 (lanes 2-5) and S1-S4 (lanes 6-9) exhibit gradually decreased mobility on a gel. As a result, the bands representing degraded oligomers overlap with bands of non-degraded ones. Overexposed gels additionally show ladders of shorter oligomers. These short 5[prime]-labeled oligomers consist of the products of enzymatic degradation of modified oligomers F1-F4 and S1-S4 due to the `hopping' properties (29,36) of human plasma 3[prime]-exonuclease with modified internucleotide linkages.

Table 4. Hybridization properties of oligo(deoxyribonucleoside methane-phosphonamidates) F2-F4 and S2-S4 with dA12 and A12. Temperature depressions caused by introduction of each modified internucleotide linkage and for two different complementary sequences are shown
Oligonucleotide Target Tma [Delta]Tmb [Delta]Tmc
T12 dA12 39.0    
F2 dA12 33.7 2.6  
F3 dA12 31.3 2.4  
F4 dA12 29.3 2.0  
S2 dA12 27.0 6.0  
S3 dA12 21.4 5.6  
S4 dA12 15.3 6.1  
T12 A12 27.3   11.7
F2 A12 23.6 1.8 10.1
F3 A12 22.3 1.3 9.0
F4 A12 21.3 1.0 8.0
S2 A12 17.3 5.0 9.7
S3 A12 13.1 4.2 8.3
S4 A12      
aTm was determined with an accuracy of ±0.5°C
bTm decrease caused by an introduction of the subsequent additional methanephosphonamidate linkage into the phosphate backbone
cDifference in Tm values for two complementary heteroduplexes formed by dA12 and A12 respectively.

Hybridization properties

DNA/DNA duplexes. As was shown by the two TpmT oligonucleotides with either the [Rp] or [Sp] phosphorus configuration, the binding affinity to complementary oligonucleotides significantly depends on the stereochemistry of the methanephosphonate units (6,25). Melting temperature measurements of duplexes obtained by hybridization of modified oligomers F1-F4 and S1-S4 with the dA12 target were performed at various oligonucleotide concentrations (1 × 10-6 - 6 × 10-6 M). The resulting Tm values as plots of Tm versus duplex concentration are included in Supplementary Material (PDF 86 KB). The thermal stability of all duplexes possessing a modified internucleotide linkage incorporated into the oligonucleotide chain is lower than that of the unmodified T12/dA12 duplex and strongly depends on the type and number of introduced internucleotide bond modifications (Table 4). The F-type modification [originating from TnpmT(fast)] lowers the Tm by ~2.4°C, whereas the S-type modification [originating from TnpmT(slow)] lowers the Tm by ~6.0°C. Since, for self-complementary octamers containing one methanephosphonate linkage introduced into the oligonucleotide chain, depression of Tm for the [Rp] diastereomer is smaller than for the [Sp] diastereomer (25), the results obtained are additional support for our assignment of the absolute phosphorus configurations in dithymidine methanephosphonamidates as [Rp] for 6a [TnpmT(fast)] and [Sp] for 6b [TnpmT(slow)]. Thermodynamic parameters ([Delta]H°, [Delta]S° and [Delta]G° at 25°C) obtained from the linear dependence 1/Tm versus ln[total strand concentration] (30) show no statistically significant differences for the studied oligomers (data included in Supplementary Material (PDF 86 KB)).

DNA/RNA duplexes. The stabilities of DNA/RNA duplexes are much lower than those of DNA/DNA (31). As expected, the melting temperatures of duplexes originating from F2-F4 or S2-S3 oligomers and the A12 target oligoribonucleotide are lower by 8.0-11.7°C (Table 4) as compared with those with the dA12 target oligonucleotide. This lowering of the melting temperature is smaller when oligo(deoxyribonucleoside methanephosphonamidates) are hybridized with RNA than with DNA, as compared with non-modified oligonucleotide T12. Here the F-type modification lowers Tm values by only 1.0-1.8°C, whereas the S-type modification lowers Tm values by 4.2-5.0°C. As was shown by Gryaznov et al. (9), a decathymidylate possessing phosphoramidate linkages in alternate positions exhibits a lower binding affinity for DNA targets but hybridizes better with RNA targets. In our case an introduced methanephosphonamidate linkage decreases the binding affinity of modified oligomers for complementary RNA (to a lesser extent) and DNA (to a greater extent) targets, with less effect for F-type modifications (6). The difference in hybridization properties of oligomers originating from both [TnpmT(fast) and TnpmT(slow)] diastereomeric units could be caused by different steric perturbations (6) as well as different hydration patterns (12,35) of duplexes caused by the presence of a methyl group in the modified phosphate backbone.


Figure 4. Thermal denaturation profiles of complexes of oligo(deoxyribonucleoside methanephosphonamidates) F4 and S4 and dodecathymidylate T12 hybridized with the d(A21C4T21) hairpin (HP) oligomer. The transitions of hairpin to single-stranded oligomers are observed in the temperature range 60-90°C. The clear transition of triplex to duplex is observed in the range 3-35°C for the F4/HP complex (insert).


Triplex formation

Since it is well known that homopolymers of thymidine have the ability to bind to poly(dA)·poly(T) duplex oligonucleotides by Hoogsteen hydrogen bonds giving rise to stable triplex structures of the T*dA·T type (32,33), melting temperature experiments were performed with dodecathymidylates T12, F4 and S4 and the duplex oligonucleotide hairpin oligomer d(A21C4T21). An increase in UV absorption at temperatures >60°C represents transition of the hairpin structure to single-stranded oligomer (Fig. 4). All the melting profiles for T12/d(A21C4T21), F4/d(A21C4T21) and S4/d(A21C4T21) triplexes are similar in this region. However, the profiles of those melting curves are significantly different at lower temperatures (3-50°C, insert in Fig. 4). The curve observed for oligonucleotide F4 complexed with hairpin oligomer d(A21C4T21) clearly shows an upper part of triplex-duplex transition, in contrast to the lack of such clear transitions for the remaining complexes. Despite a low binding affinity of the dodecathymidylates, due to the length of the chain, for hairpin d(A21C4T21), F-type oligodeoxyribonucleotide modification enhances triplex formation (34). In contrast, S-type modification, present in oligomer S4, does not improve its affinity for the hairpin d(A21C4T21) and decreases triplex stability, as compared with the unmodified triplex structure. Heating and cooling curves (0.2°C/min) recorded for T12/d(A21C4T21) or F4/d(A21C4T21) triplexes do not exhibit any significant hysteresis for triplex-duplex transitions (data not shown). Further hybridization studies on longer chimeric oligo(deoxyribonucleoside methanephosphonamidates) concerning their tendency to form triplex structures are in progress.

CONCLUSIONS

Diastereomeric dithymidine methanephosphonamidates 4a and 4b were obtained by reaction of 3[prime]-amino-3[prime]-deoxythymidine with 3[prime]-O-acetylthymidin-5-yl-methanephosphonchloridate. Successful separation of the diastereomers was achieved by silica gel column chromatography with a methanol/chloroform gradient, giving rise to fast migrating diastereomer 4a [TnpmT(fast)] and slow migrating diastereomer 4b [TnpmT(slow)]. By comparison with the stereochemistry of dinucleoside methanephosphonates tentative assignment of the absolute configuration at the phosphorus atom of [Rp] for diastereomer 4a and [Sp] for diastereomer 4b is proposed. Selective removal of the 3[prime]-terminal protecting group from 4a and 4b and subsequent phosphitylation with 2-cyanoethyl tetraisopropylphosphordiamidite gave 7a and 7b respectively, which were used as building blocks for automated solid phase synthesis of oligodeoxyribonucleotides. Chimeric dodecathymidylates F1-F4 and S1-S4, possessing one to four modified linkages originating from diastereomers TnpmT(fast) or TnpmT(slow) respectively, were obtained. Stability of dimeric methanephosphonamidates 6a and 6b to nuclease P1 and svPDE as well stability of dodecathymidylates F1-F4 and S1-S4 to nuclease P1 and 3[prime]-exonuclease from human plasma show a complete resistance of the methanephosphonamidate linkage to nucleolytic degradation. The binding affinities of chimeric dodecathymidylates for single-stranded DNA and RNA as well as double-stranded DNA strongly depend on the stereochemistry of the methanephosphonamidate units. In general, both chimeric dodecathymidylate series possess lower binding affinities for complementary single-stranded oligonucleotides in comparison with the binding properties of non-modified dodecathymidylate. However, chimeric dodecathymidylates F1-F4, originating from diastereomer TnpmT(fast), exhibit better hybridization properties in comparison with dodecathymidylates S1-S4, originating from diastereomer TnpmT(slow). Moreover, chimeric dodecathymidylate F4, possessing four methanephosphonamidate linkages in alternate positions, exhibits a higher binding affinity for hairpin d(A21C4T21) in comparison with the T12 and S4 oligomers. Modification of the oligodeoxyribonucleotide phosphate backbone with F-type methanephosphonamidate linkages enhances triplex stability.

In summary, the stability against enzymatic degradation and the configurational differentiation with respect to binding affinity of [Rp] and [Sp] oligo(deoxyribonucleoside methanephosphonamidates) for single-stranded DNA and RNA as well double-stranded DNA could be of interest for further investigation.

ACKNOWLEDGEMENTS

This project was supported by The State Committee for Scientific Research (KBN) grant 4P05F 02310 (to W.J.S.). The authors are indebted to Mrs Wieslawa Goss for excellent technical assistance.

See Supplementary Material (PDF 86 KB) available in NAR Online.

REFERENCES

1. Uhlmann,E. and Peyman,A. (1990) Chem. Rev., 90, 544-584.

2. Crooke,S.T. and Lebleu,B. (1993) Antisense Research and Applications. CRC Press, Boca Raton, FL.

3. Lesnikowski,Z.J., Jaworska,M. and Stec,W.J. (1988) Nucleic Acids Res., 16, 11675-11689. MEDLINE Abstract

4. Lesnikowski,Z.J., Jaworska,M. and Stec,W.J. (1990) Nucleic Acids Res., 18, 2109-2115. MEDLINE Abstract

5. Agrawal,S., Temsamani,J., Galbraith,W. and Tang,J. (1995)Clin. Pharmacokinet., 28, 7-16. MEDLINE Abstract

6. Reynolds,M.A., Hogrefe,R.I., Jaeger,J.A., Schwartz,D.A., Riley,T.A., Marvin,W.B., Daily,W.J., Vaghefi,M.M., Beck,T.A., Knowles,S.K., Klem,R.E. et al). (1996) Nucleic Acids Res. 24, 4584-4591. MEDLINE Abstract

7. Agrawal,S. and Zhang,R. (1997) Ciba Foundn Symp., 209, 60-75.

8. Zhou-Sun,B., Sun,J., Gryaznov,S.M., Liquier,J., Garestier,T., Hélène,C. and Taillandier,E. (1997) Nucleic Acids Res., 25, 1782-1787. MEDLINE Abstract

9. Gryaznov,S.M. and Chen,J. (1994) J. Am. Chem. Soc., 116, 3143-3144.

10. Chen,J., Schultz,R.G., Lloyd,D.H. and Gryaznov,S.M. (1995)Nucleic Acids Res., 23, 2661-2668. MEDLINE Abstract

11. Gryaznov,S.M., Skorski,T., Cucco,C., Nieborowska-Skorska,M., Chiu,C.Y., Lloyd,D.H., Chen,J., Koziolkiewicz,M. and Calabretta,B. (1996) Nucleic Acids Res., 24, 1508-1514.

12. Barsky,D., Colvin,M.E., Zon,G. and Gryaznov,S.M. (1997)Nucleic Acids Res., 25, 830-935. MEDLINE Abstract

13. Koziolkiewicz,M., Wójcik, M., Kobylanska,A., Karwowski,B., Rebowska,B., Guga,P. and Stec,W.J. (1997) Antisense Nucleic Acids Drug Dev., 7, 43-48.

14. Agarwal,K.L. and Riftina,F. (1979) Nucleic Acids Res., 6, 3009-3024. MEDLINE Abstract

15. Zon,G. and Stec,W.J. (1991) In Eckstein,F. (ed.), Oligonucleotides and Analogues. A Practical Approach. IRL Press at Oxford University Press, Oxford, pp. 87-108.

16. Altona,C. and Sundaralingam,M. (1973) J. Am. Chem. Soc., 95, 2333-2344. MEDLINE Abstract

17. Saenger,W. (1984) Principles in Nucleic Acid Structure. Springer-Verlag, New York, NY.

18. Thibaudeau,C., Plavec,J., Garg,N., Papchikhin,A. and Chattopadhyaya,J. (1994) J. Am. Chem. Soc., 116, 4038-4043.

19. Ding,D., Gryaznov,S.M., Lloyd,D.H., Chandrasekaran,S., Yao,S., Ratmeyer,L., Pan,Y. and Wilson,W.D. (1996) Nucleic Acids Res., 24, 354-360. MEDLINE Abstract

20. Rinkel,L.J. and Altona,C. (1987) J. Biomol. Struct. Dyn., 4, 621-649. MEDLINE Abstract

21. Wozniak,L.A., Wieczorek,M., Pyzowski,J., Majzner,W. and Stec,W.J. (1998) J. Org. Chem., in press.

22. Löschner,T. and Engels,J.W. (1990) Nucleic Acids Res., 18, 5083-5088. MEDLINE Abstract

23. Wang,C., Wang,L., Yang,X., Jiang,T. and Zhang,L. (1993) Nucleic Acids Res., 21, 3245-3248. MEDLINE Abstract

24. Lebedev,A.V., Frauendorf,A., Vyazovkina,E.V. and Engels,J.W. (1993) Tetrahedron, 49, 1043-1052.

25. Bower,M., Summers,M.F., Powell,C., Shinozuka,K., Regan,J.B., Zon,G. and Wilson,W.D. (1987) Nucleic Acids Res., 15, 4915-4930. MEDLINE Abstract

26. Chacko,K.K., Lindner,K. and Saenger,W. (1983) Nucleic Acids Res., 18, 2109-2115.

27. Han,F., Watt,W., Callahan,L., Kezdy,F.J. and Agarwal,K.L. (1986)Proc. Natl. Acad. Sci. USA, 83, 1617-1621.

28. Caruthers,M.H. (1985) Science, 230, 281-285. MEDLINE Abstract

29. Stec,W.J., Zon,G., Egan,W. and Stec,B. (1984) J. Am. Chem. Soc., 106, 6077-6079.

30. Breslauer,K.J. (1994) In Agrawal,S. (ed.), Methods in Molecular Biology, Vol. 26, Protocols for Oligonucleotide Conjugates. Humana Press, Totowa, NJ, pp. 347-372.

31. Clark,C.L., Cecil,P.K., Singh,D. and Gray,D.M. (1997) Nucleic Acids Res., 25, 4098-4105. MEDLINE Abstract

32. Thuong,N.T. and Hélène,C. (1993) Angew. Chem. Int. Edn English, 32, 666-690.

33. Giovannangeli,C. and Hélène,C. (1997) Antisense Nucleic Acids Drug Dev., 7, 413-421.

34. Hausheer,F.H., Singh,U.C., Saxe,J.D., Colvin,O.M. and T'so,P.O.P. (1990) Anti-Cancer Drug Design, 5, 159-167. MEDLINE Abstract

35. Tereshko,V., Gryaznov,S. and Egli,M. (1998) J. Am. Chem. Soc., 120, 269-283.

36. Ozaki,H., Kitamura,M., Yamana,K., Murakami,A. and Shimidzu,T. (1990) Bull. Chem. Soc. Jpn, 63, 1929-1936.


*To whom correspondence should be addressed. Tel: +48 42 81 97 44; Fax: +48 42 81 54 83; Email: bnawrot@lodz.pdi.net


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: www-admin{at}oup.co.uk
Last modification: 19 May 1998
Copyright©Oxford University Press, 1998.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Print PDF (129K) Freely available
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Nawrot, B.
Right arrow Articles by Stec, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nawrot, B.
Right arrow Articles by Stec, W. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?